Literature DB >> 21509679

Epidemiology of multiple myeloma.

Nikolaus Becker1.   

Abstract

Multiple myelomas are a less frequent cancer site among both sexes. On a worldwide scale, it is estimated that about 86 000 incident cases occur annually, accounting for about 0.8% of all new cancer cases. About 63 000 subjects are reported to die from the disease each year, accounting for 0.9% of all cancer deaths. Geographically, the frequency is very unevenly distributed in the world with the highest incidence in the industrialised regions of Australia / New Zealand, Europe and North America. Incidence and mortality seem to be stable in Asian countries and to increase slowly over the decades among whites in the western countries. The etiology is poorly understood. This depends partly upon the fact that the risk factors which play a major role for malignant diseases in general, such as tobacco consumption and diet have not been found strongly involved into multiple myeloma etiology. Nevertheless, some consistency seems to be in the findings about a risk elevation with obesity and a slightly decreased risk with high fruit consumption. Despite some contradicting results, indications to a role of ionising radiation persist. Finally, infections with HIV and hepatitis C virus appear related to an elevated multiple myeloma risk. Currently, large efforts are undertaken to unravel the etiology of malignant lymphoma including those of multiple myeloma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21509679     DOI: 10.1007/978-3-540-85772-3_2

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  70 in total

1.  Why proteasome inhibitors cannot ERADicate multiple myeloma.

Authors:  Robert Z Orlowski
Journal:  Cancer Cell       Date:  2013-09-09       Impact factor: 31.743

2.  Medication use and multiple myeloma risk in Los Angeles County.

Authors:  Daniel S Nuyujukian; Jenna Voutsinas; Leslie Bernstein; Sophia S Wang
Journal:  Cancer Causes Control       Date:  2014-07-01       Impact factor: 2.506

3.  Systematic review and meta-analysis of glyphosate exposure and risk of lymphohematopoietic cancers.

Authors:  Ellen T Chang; Elizabeth Delzell
Journal:  J Environ Sci Health B       Date:  2016-03-25       Impact factor: 1.990

4.  Phase 1 study of ixazomib alone or combined with lenalidomide-dexamethasone in Japanese patients with relapsed/refractory multiple myeloma.

Authors:  Kenshi Suzuki; Hiroshi Handa; Takaaki Chou; Kenichi Ishizawa; Takatoshi Takubo; Yoichi Kase
Journal:  Int J Hematol       Date:  2016-12-20       Impact factor: 2.490

Review 5.  The evolution of stem-cell transplantation in multiple myeloma.

Authors:  Sarakshi Mahajan; Nidhi Tandon; Shaji Kumar
Journal:  Ther Adv Hematol       Date:  2018-03-05

6.  New complex chromosome abnormalities in multiple myeloma associated with a poor prognosis: a case report.

Authors:  Agnes C Fett-Conte; Andréa B Carvalho-Salles; Cristina B Vendrame; Patrícia Pedrassa; Paula C Freitas; Marileila Varella-Garcia
Journal:  Leuk Res       Date:  2012-04-12       Impact factor: 3.156

7.  Aberrant promoter methylation of p15 (INK⁴b) and p16 (INK⁴a) genes may contribute to the pathogenesis of multiple myeloma: a meta-analysis.

Authors:  Xuan Wang; Yan-Bin Zhu; Hai-Peng Cui; Ting-Ting Yu
Journal:  Tumour Biol       Date:  2014-06-08

8.  Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma.

Authors:  Michelle M McDonald; Michaela R Reagan; Scott E Youlten; Sindhu T Mohanty; Anja Seckinger; Rachael L Terry; Jessica A Pettitt; Marija K Simic; Tegan L Cheng; Alyson Morse; Lawrence M T Le; David Abi-Hanna; Ina Kramer; Carolyne Falank; Heather Fairfield; Irene M Ghobrial; Paul A Baldock; David G Little; Michaela Kneissel; Karin Vanderkerken; J H Duncan Bassett; Graham R Williams; Babatunde O Oyajobi; Dirk Hose; Tri G Phan; Peter I Croucher
Journal:  Blood       Date:  2017-05-17       Impact factor: 22.113

9.  Deguelin, a natural rotenoid, inhibits mouse myeloma cell growth in vitro via induction of apoptosis.

Authors:  Zhengguang Li; Jun Wu; Changping Wu; Jingting Jiang; Xiao Zheng; Bin Xu; Min Li
Journal:  Oncol Lett       Date:  2012-07-06       Impact factor: 2.967

10.  Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis.

Authors:  Quan Li; Long Liu; Weiming Li
Journal:  Tumour Biol       Date:  2014-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.